veronapharma.com Report : Visit Site

Technical data of the veronapharma.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host veronapharma.com. Currently, hosted in United Kingdom and its service provider is Cloud Servers UK IP Space .

the related websites

terrapinn.com geticket.it walmart.com airportdirecttravel.co.uk sewingworkshop.com argos.co.uk bet365.com nfs.sparknotes.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache/2.4.7 containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

menu search breathtaking science developing innovative therapeutics to transform the standard of care for respiratory diseases search for better science we aim to build a strong clinical r&d pipeline to target debilitating respiratory diseases our science targeting respiratory diseases with significant unmet medical needs. there are millions of patients suffering globally from chronic, debilitating respiratory conditions that are not well treated by existing medicines. there is a real and pressing need for new treatments. we are focused on developing these treatments. our efficient r&d; outsourcing model gives us access to leading experts and organisations around the globe and our agility and focus on our core competencies provide the highest standards of pre-clinical and clinical development. see our product pipeline our strategy to progress projects with high commercial potential, whilst delivering both near-and long-term value to our shareholders. we have a clear view of the medical need and commercial potential of our novel products in global, multi-billion dollar markets. making the right decisions now, with partners and investors, will help us identify the quickest and most effective route to market allowing us to potentially transform the lives of patients suffering from these debilating diseases, with the returns enabling us to continue this mission into the future. find out more about us verona pharma verona pharma plc is a clinical stage biopharmaceutical company focused on the development and commercialization of innovative prescription medicines to treat respiratory diseases with significant unmet medical needs, such as copd and cystic fibrosis. the company is listed on the nasdaq global market in the united states under the vrna ticker and on the london stock exchange in the united kingdom under the vrp.l ticker. read more here about verona pharma's science and innovative theraputics. latest press releases 30 may 2018 verona pharma to present at upcoming investor conferences london, may 30, 2018 (globe newswire) -- verona pharma plc (aim:vrp) (nasdaq:vrna… 23 may 2018 verona pharma files shelf registration statement with sec london, may 23, 2018 (globe newswire) -- verona pharma plc (aim:vrp) (nasdaq:vrna… press releases regulatory news video unique mechanism of action our breakthrough lead product, rpl554, is first-in-class. it offers a unique, dual mechanism of action unlike any other type of drug currently available or in development for respiratory diseases go current share price 155.00p 0.00 (0.00%) lon: vrp 16.96usd 0.66 (4.05%) nasdaq: vrna go to lse go to nasdaq quick links investor information board of directors shareholders senior management shareholder circulars financial performance contact us verona pharma plc 3 more london riverside london se1 2re united kingdom e: [email protected] t: +44 (0)203 283 4200 see location on map email alerts registered address one central square cardiff cf10 1fs united kingdom us investor relations contact icr, inc. e: [email protected] t: +1 646-277-1282 uk investor relations contact fti consulting e: [email protected] t: +44 (0)20 3727 1000 nominated adviser and broker stifel nicolaus europe limited 150 cheapside london ec2v 6et united kingdom t: +44 (0)207 710 7600 verona pharma plc 3 more london riverside, london se1 2re t: +44 (0)203 283 4200 e: [email protected] © verona pharma plc 2018 email alerts website terms and conditions legal information cookies site map close home about us company overview strategy and business model board of directors senior management our science our science product pipeline unique mechanism of action clinical development clinical and scientific advisory board unmet need chronic obstructive pulmonary disease cystic fibrosis investors investor information ir contacts faqs shareholder information capital structure aim rule 26 shareholder warning shareprice information analyst coverage key advisers regulatory news and sec filings events and presentations financial performance corporate governance board of directors, management and committees corporate social responsibility shareholder circulars news and media news videos download centre contact us verona pharma plc 3 more london riverside, london se1 2re t: +44 (0)203 283 4200

URL analysis for veronapharma.com

http://www.veronapharma.com///about-us/
http://www.veronapharma.com///corporate-governance/
http://www.veronapharma.com///our-science/#our-science-unique-mechanism-of-action
http://www.veronapharma.com///our-science/#our-science-clinical-development
http://www.veronapharma.com///blog/verona-pharma-files-shelf-registration-statement-with-sec/
http://www.veronapharma.com///cookies/#cookies
http://www.veronapharma.com///news-and-media/videos/
http://www.veronapharma.com///corporate-governance/#corporate-governance-corporate-social-responsibility
http://www.veronapharma.com///about-us/board-of-directors/
http://www.veronapharma.com///unmet-need/
http://www.veronapharma.com///search/
http://www.veronapharma.com///unmet-need/#unmet-need-cystic-fibrosis
http://www.veronapharma.com///news-and-media/#news-and-media-news
http://www.veronapharma.com///about-us/senior-management/
http://www.veronapharma.com///website-terms/#website-terms
thinkerdoer.co.uk

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: VERONAPHARMA.COM
Registry Domain ID: 334071742_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.123-reg.co.uk
Registrar URL: http://www.meshdigital.com
Updated Date: 2016-12-02T06:59:31Z
Creation Date: 2006-02-03T06:02:23Z
Registry Expiry Date: 2019-02-03T06:02:23Z
Registrar: 123-Reg Limited
Registrar IANA ID: 1515
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS.123-REG.CO.UK
Name Server: NS2.123-REG.CO.UK
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-09-11T03:22:01Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR 123-Reg Limited

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =veronapharma.com

  PORT 43

  TYPE domain

DOMAIN

  NAME veronapharma.com

  CHANGED 2016-12-02

  CREATED 2006-02-03

STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited

NSERVER

  NS.123-REG.CO.UK 212.67.202.2

  NS2.123-REG.CO.UK 62.138.132.21

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .